U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07113379) titled 'Study for Prevention of Cervical Cancer in Spain' on July 24.
Brief Summary: The REVIVE study aims to analyze the current status of Human Papillomavirus (HPV) vaccination programs and cervical cancer screening strategies in Spain. Its objective is to gain a comprehensive understanding of the effectiveness of these preventive measures, as well as to identify the main barriers to access and the existing inequalities in care. The study will also examine the impact of misinformation on population engagement and on the overall equity of the prevention system.
Despite significant advances in both vaccination and screening efforts, cervica...